Aquinox Pharma Cash Flow - Quarterly (NASDAQ:AQXP)

Add to My Stocks
$14.28 $0.14 (0.97%) AQXP stock closing price Mar 20, 2018 (Closing)

For analyzing any company like Aquinox Pharma from an investment perspective, its important to check the cash flow statement. The profit-loss statement shows Aquinox Pharma profits, the balance sheet shows Aquinox Pharma debt, and the cash flow statement reflects the liquidity and solvency of a firm. This statement reflects the company's ability to generate cash flows. Aquinox Pharma had cash and cash equivalents of $39.52M at beginning of the quarter and $47.1M at quarter end of 2017 Q3. Aquinox Pharma cash flow analysis tells whether or not the company has enough cash for its day to day activities, and for investing for future growth. Aquinox Pharma had an outflow of $-33.11M from operating activities, $- spend due to financing activities, and $47.52M inflow due to investing activities till 2017 Q3.

View and download details of Aquinox Pharma cash flows for latest & last 40 quarters
show more
View Previous Quarters
View Next Quarters
Fiscal year is Jan - Dec2017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42015 Q3
Net Income Cash Flow
Depreciation Depletion Amortization Cash-Flow---------
Net Increase (Decrease) in Assets Liabilities-2.54M-1.45M-3.74M4.7M3.08M2.93M--0.54M-1.83M
Cash From (used in) Discontinued Operations---------
Other Adjustments Net3.34M1.95M-2.07M1.44M--2.13M1.25M
Net Cash from (used by) Operating Activities
Increase (Decrease) in Prop Plant And Equipment-0.47M-0.45M-0.1M-0.71M-0.61M-0.32M-0.02M-0.02M-0.01M
Acquisition Disposition of Subsidiaires---------
Increase (Decrease) in Investments48M16.5M--47.34M-2.73M-2.98M2.02M-47.5M18.16M
Other Cash Inflow (Outflow) from Investment Activities---------
Net Cash from (used by) Investment Activities
Issuance (Purchase) of Equity Shares---75.8M75.8M--99.15M99.15M
Issuance (Repayment) of Debt Securities-0.01M-0.01M-------
Increase (Decrease) in Bank & Other Borrowings---------
Payment of Dividends & Other Cash Distributions---------
Other Cash from (used by) Financing Activities----4.69M-4.53M---6.21M-6.06M
Net Cash from (used by) Financing Activities
Effect of Exchange Rate Changes on Cash----0.05M----0.52M-
Net Change in Cash & Cash Equivalents
Cash & Equivalents at Beginning of Year39.52M14.9M11M2M9.23M----
Cash & Equivalents at Year End47.1M27.14M20.91M32.3M86.22M22.47M35.69M39.52M109.37M
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters

Aquinox Pharma stock price history provides insight into historical stock price fluctuations, and Aquinox Pharma stock comparison chart enables peer comparison. Some of the key terms used in the statement of cash flows are:

  • Aquinox Pharma saw a positive change in Net Change in Cash and Cash Equivalents of $14.8M till 2017 Q3. Apart from the Aquinox Pharma stock price, this is one of the things an investor looks for, as it shows the net change in cash on hand for a company, compared to previous period.
  • Aquinox Pharma decreased its cash from operating activities to $-33.11M till 2017 Q3. Operating activities include production of goods or creating a product or providing a service, and collecting payment for the same from customers. The cash generated from these activities is refered to as cash flow from operating activities.
  • Cash Flow from investment activities: Aquinox Pharma generated $47.52M cash due to investment activities. It includes the use of cash outside of normal day to day activities like buying fixed assets, plant and machinery etc.
  • Cash flow from financing activities shows the flow of cash between Aquinox Pharma and its owners and creditors and was $- till 2017 Q3. Financing activities allow a company to raise capital, and repay bondholders.

Key Financial Ratios For Aquinox Pharma Cash Flow

Quarterly Cash Flow Statements For Aquinox Pharmaceuticals Inc Peers

Akebia Therapeutics cash flow, Ardelyx cash flow, Corium cash flow, Keryx Biopharma cash flow, Progenics Pharma cash flow